Get up-to-date information by listening to a free replay of our April teleconference hosted in partnership with the Triple Negative Breast Cancer Foundation, Triple-Negative Breast Cancer: Research and Treatment Update.

Lisa A. Carey, MD, ScM, of the University of North Carolina Breast Center, provided new information on triple-negative breast cancers, or cancers that test negative for the estrogen and progesterone receptor and HER2 protein, including:

• The latest information, research and treatments
• The causes of this diagnosis
• Factors that may make triple-negative disease more difficult to treat in early and advanced breast cancers

About Our Speaker

Dr. Carey is an associate professor in the University of North Carolina department of medicine’s division of hematology-oncology. She has served since 2003 as the medical director of the UNC Breast Center and is the UNC-Lineberger Comprehensive Cancer Center (UNC-LCCC) Protocol Office executive committee breast disease group leader as well as the UNC-LCCC Protocol Review Committee breast cancer chair.

Dr. Carey has an interest in clinical/translational research in breast cancer, with a particular interest in the clinical implications of different molecular subtypes of breast cancer. She designs and leads clinical trials and often works with laboratory investigators. Dr. Carey has served on the American Society of Clinical Oncology (ASCO) Scientific Program Committee and as faculty for the ASCO annual meeting for several years. She was named to the Cancer and Leukemia Group B (CALGB) Breast Core Committee in 2003. She was awarded a Doris Duke clinician scientist award in 1999 and a career development award from the National Cancer Institute in 2000.

About the Program

To download this program, you needReal Network Player or Windows Media Player.

Our Sponsor

This teleconference is made possible through the generous support of Susan G. Komen for the Cure.

Listen to a free replay of this teleconference.